Final PDUFA Package Heeds FDA Calls for More Supply Chain Powers

Drug GMP Report
A A
House and Senate leaders have agreed on a final FDA user fee reauthorization package that provides the agency with most of the increased supply chain oversight powers it asked for, including new authority to stop drug imports by uncooperative foreign manufacturers and new abilities to share information with other international regulators.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $40.00